Avava, Inc.

Avava, Inc. is a medical aesthetics company specializing in precision laser and energy-based skin treatment systems. The company's flagship product is the AVAVA® laser platform, which utilizes proprietary Focal Point Technology™ for targeted energy delivery at multiple skin depths and ComfortCool™ integrated cooling technology to enhance patient comfort while minimizing unintended thermal damage to surrounding tissue. The system is designed to address diverse skin tones and skin types, offering personalized skin renewal treatments including resurfacing and revitalization with minimal downtime. The company also develops digital ecosystem solutions including MyAVAVA™ patient engagement software and AVAVASyncPro™ provider management tools. Avava is founded by leading dermatological researchers affiliated with Massachusetts General Hospital and Harvard Medical School, including Dr. R. Rox Anderson (Director of Wellman Center for Photomedicine), Dr. Dieter Manstein, and Dr. Henry H.L. Chan. The company markets its technology to aesthetic providers and clinics globally and operates a provider network model. No FDA clearance status, ISO certification, or CE marking is explicitly mentioned on the fetched website content.